IMMX Q1 2026 Earnings Smallerthanexpected loss drives positive sentiment U Q1 2026 Earnings Narrower Loss Beats Estimates as Cost Initiatives Gain Traction C3ai Q1 2026 Earnings WiderThanExpected Loss and Tepid Market Reception VELO Q1 2026 Earnings Narrowed Loss Exceeds Expectations Shares Rise 9 Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline NE Q1 2026 Earnings EPS Beats by 301 on Robust Operational Performance